InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Patel Sanjiv, Chief Executive Officer. Director active across 2 companies, notably Relay Therapeutics, Inc.. Cumulatively, 23 reports have been logged. Breakdown: 0 buy · 8 sells. Total volume traded: €3.8m. Activity tracked since 31 December 2021. The latest transaction was disclosed on 17 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Patel Sanjiv
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
48,199 shares@ US$20.33Common StockSEC:0001193125-26-355502:0
3,056 shares@ US$6.950.0005% mcap0.6% of flowCommon StockSEC:0001193125-26-298681:0
48,199 shares@ US$19.580.023% mcap26.1% of flowCommon StockSEC:0001193125-26-298681:1
994 shares@ US$2.990.1% of flowCommon StockSEC:0001193125-26-006328:0
62,073 shares@ US$7.0010.3% of flowCommon StockSEC:0001193125-25-264700:0
42,740 shares@ US$3.574.0% of flowCommon StockSEC:0000950170-25-095093:0
5,000 shares@ US$2.940.4% of flowCommon StockSEC:0000950170-25-092305:0
42,769 shares@ US$2.974.9% of flowCommon StockSEC:0000950170-25-057996:0
140,182 shares@ US$3.8522.7% of flowCommon StockSEC:0000950170-25-020272:0
125,000 shares@ US$4.5223.5% of flowCommon StockSEC:0000950170-25-008451:0
100,000 shares@ US$5.0020.6% of flowCommon StockSEC:0000950170-24-137960:0
50,000 shares@ US$5.0410.1% of flowCommon StockSEC:0000950170-24-087435:0
2,108 shares@ US$5.540.5% of flowCommon StockSEC:0000950170-24-079693:0
762,360 shares0Common StockSEC:0001209191-24-001843:0
1,662 shares@ US$10.684.0% of flowCommon StockSEC:0001209191-23-050874:0
14,000 shares@ US$5.042.8% of flowCommon StockSEC:0001209191-23-008072:0
28,000 shares@ US$5.045.6% of flowCommon StockSEC:0001209191-23-004127:0
14,000 shares@ US$4.122.5% of flowCommon StockSEC:0001209191-22-056427:0
14,000 shares@ US$4.122.6% of flowCommon StockSEC:0001209191-22-053597:0
14,000 shares@ US$4.122.5% of flowCommon StockSEC:0001209191-22-050182:0
814 shares@ US$14.240.5% of flowCommon StockSEC:0001209191-22-041639:0
28,000 shares@ US$4.1287.5% of flowCommon StockSEC:0001209191-22-024487:0
658 shares@ US$26.1012.5% of flowCommon StockSEC:0001209191-22-002465:0
23 of 23 declarations
About Patel Sanjiv
Patel Sanjiv is Directeur Général and President and CEO at Relay Therapeutics, Inc. The 22 filings recorded cover the period from 2022-01-07 to 2026-07-08, with EUR 0 in purchases and EUR 2985493 in sales across the sampled recent filings. The largest filings shown are a sale of EUR 824542.5340883769 on 2026-07-08, then EUR 542190.9781637071 on 2025-01-23, EUR 523903.6637223939 on 2025-02-13, EUR 475735.0191476839 on 2024-12-18, EUR 376916.5475686016 on 2025-11-04, and another-type transaction of EUR 232230.60194342 on 2024-07-29.
